Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide ...

Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics PRESS RELEASE GlobeNewswire Jan. 13, 2021, 02:00 AM ... Read More

Update on Finalization of MCIT Rule to Provide National Medicare ...

Centers for Medicare & Medicaid Services (CMS) will delay the implementation date of the MCIT rule by 60 days, beginning a 30-day comment period to solicit additional public feedback on the rule. Read More

Lawmakers press CMS to release new breakthrough device coverage rule

Lawmakers echoed device makers' call for an easier pathway to CMS reimbursement of medical device breakthroughs at a congressional hearing Wednesday. Read More

Finalization of MCIT rule for coverage pathway | Regulatory News

Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics Creates Pathway for Beneficiary Access to KidneyIntelX ... Read More

CMS Should Offer Immediate Reimbursement Coverage To FDA ... - Forbes

The Centers for Medicare & Medicaid Services can advance underserved elderly patients' access to the newest device treatment options by implementing a delayed new rule. Read More

New CMS rule to enable immediate coverage for FDA-designated ...

The agency has finalized a rule that allows it to provide immediate Medicare coverage for FDA-approved products that are deemed "breakthrough devices." The new coverage process would enable ... Read More

CMS' rule granting speedy coverage to FDA-designated 'breakthrough ...

CMS delayed the start date of its rule that would provide expedited Medicare coverage for products the FDA deems "breakthrough devices" from May 15 to Dec. 15. CMS wants more time to examine ... Read More

CMS finalizes reimbursement rule for breakthrough devices

CMS' TCET program expedites coverage for FDA breakthrough medical devices. A bill is also making its way through Congress that would replace the rule. Read More

AdvaMed pushes CMS to implement MCIT final rule ... - Healthcare Dive

The Medicare Coverage of Innovative Technology rule would provide national Medicare coverage of breakthrough devices for four years, starting at the time of FDA marketing authorization. At the end ... Read More

Renalytix Commends HHS/CMS on Finalization of MCIT Rule to Provide ...

Under MCIT, national Medicare coverage can become effective on the date of FDA approval or clearance of a breakthrough designated device and will continue for a period of four years. Read More

Update on Finalization of MCIT Rule to Provide National Medicare ...

NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of ... Read More